Theseus Pharmaceuticals Statistics
Total Valuation
MoneyHero has a market cap or net worth of $72.15 million. The enterprise value is $36.57 million.
Important Dates
The next estimated earnings date is Thursday, September 18, 2025, before market open.
| Earnings Date | Sep 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MoneyHero has 43.20 million shares outstanding. The number of shares has increased by 76.49% in one year.
| Current Share Class | 29.95M |
| Shares Outstanding | 43.20M |
| Shares Change (YoY) | +76.49% |
| Shares Change (QoQ) | -34.71% |
| Owned by Insiders (%) | 8.15% |
| Owned by Institutions (%) | 17.17% |
| Float | 19.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.83 |
| Forward PS | 0.73 |
| PB Ratio | 1.61 |
| P/TBV Ratio | 1.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.37 |
| Quick Ratio | 2.06 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -898.37 |
Financial Efficiency
Return on equity (ROE) is -47.13% and return on invested capital (ROIC) is -28.59%.
| Return on Equity (ROE) | -47.13% |
| Return on Assets (ROA) | -17.93% |
| Return on Invested Capital (ROIC) | -28.59% |
| Return on Capital Employed (ROCE) | -58.61% |
| Revenue Per Employee | $250,524 |
| Profits Per Employee | -$94,882 |
| Employee Count | 286 |
| Asset Turnover | 0.77 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MoneyHero has paid $56,928 in taxes.
| Income Tax | 56,928 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.70% in the last 52 weeks. The beta is 1.15, so MoneyHero's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | +5.70% |
| 50-Day Moving Average | 1.08 |
| 200-Day Moving Average | 1.01 |
| Relative Strength Index (RSI) | 59.52 |
| Average Volume (20 Days) | 660,357 |
Short Selling Information
The latest short interest is 236,582, so 0.55% of the outstanding shares have been sold short.
| Short Interest | 236,582 |
| Short Previous Month | 226,193 |
| Short % of Shares Out | 0.55% |
| Short % of Float | 1.20% |
| Short Ratio (days to cover) | 0.71 |
Income Statement
In the last 12 months, MoneyHero had revenue of $71.65 million and -$27.14 million in losses. Loss per share was -$0.76.
| Revenue | 71.65M |
| Gross Profit | 10.59M |
| Operating Income | -26.68M |
| Pretax Income | -172.54M |
| Net Income | -27.14M |
| EBITDA | -26.35M |
| EBIT | -26.68M |
| Loss Per Share | -$0.76 |
Full Income StatementBalance Sheet
The company has $36.63 million in cash and $1.05 million in debt, giving a net cash position of $35.59 million or $0.82 per share.
| Cash & Cash Equivalents | 36.63M |
| Total Debt | 1.05M |
| Net Cash | 35.59M |
| Net Cash Per Share | $0.82 |
| Equity (Book Value) | 44.84M |
| Book Value Per Share | 1.04 |
| Working Capital | 42.47M |
Full Balance SheetMargins
Gross margin is 14.77%, with operating and profit margins of -37.24% and -37.87%.
| Gross Margin | 14.77% |
| Operating Margin | -37.24% |
| Pretax Margin | -37.79% |
| Profit Margin | -37.87% |
| EBITDA Margin | -36.78% |
| EBIT Margin | -37.24% |
| FCF Margin | n/a |
Dividends & Yields
MoneyHero does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -76.49% |
| Shareholder Yield | -76.49% |
| Earnings Yield | -37.61% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for MoneyHero is $4.00, which is 139.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 139.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 8.18% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
